# CytOSorb TreatMent Of Critically Ill PatientS Registry

> **NCT05146336** · — · RECRUITING · sponsor: **CytoSorbents, Inc** · enrollment: 3000 (estimated)

## Conditions studied

- Septic Shock
- Acute Respiratory Distress Syndrome
- Trauma
- Rhabdomyolysis
- Cardiogenic Shock
- Pancreatitis
- Acute on Chronic Liver Failure
- Acute Liver Failure
- Burns
- Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)
- Extracorporeal Life Support
- Postoperative Endocarditis
- Hemophagocytic Lymphohistiocytoses
- Liver Transplant; Complications
- Infectious Disease
- Postoperative Vasoplegic Syndrome
- Drug Overdose
- Sepsis

## Interventions

- **DEVICE:** CytoSorb

## Key facts

- **NCT ID:** NCT05146336
- **Lead sponsor:** CytoSorbents, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2032-06
- **Final completion:** 2032-09
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05146336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05146336, "CytOSorb TreatMent Of Critically Ill PatientS Registry". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05146336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*